## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 



## 

## 

## 

## 

## 



## 

|||||Unrestricted|Year to|Year to|
|---|---|---|---|---|---|---|
||||||J~n|~J|
|||||~Fund|2022|2021|
||||Notes|E|E|9|
|Income and endowments||from|||||
|Donations<br>&legacies<br>Charitable<br>activities<br>Investments||||8,650<br>70,446|8,650<br>70,446|29,600<br>61,220<br>11|
|Total income||||9.099|1 . 98|90,831|
|Expenditure<br>on:<br>Charitable<br>acUvies||||59,216|59,216|66,165|
|Total Expenditure||||59,216|59,216|66,165|
|Net Income||||19,MO|19,880|24,666|
|Transfers<br>between|funds||||||
|Net outgoing<br>resources before other||||19,880|19,880|24,666|
|recognised<br>gains and losses|||||||
|Net movement<br>in|funds|||19,880|19,880|24,666|
|Reconclgatlon<br>of|||||||
|Funds:|||||||
|Total funds brought|forward|||75,130|75,130||
|Total Funds carried forward||||95,010|95.010|75,130|
|AU ofthe results derive from continuing|||activities,||||





## 

||||~1/2022|$1/01/2021|
|---|---|---|---|---|
|Curmnt assets|||||
|Debtors||10|600|785|
|Cash at bank|and in hand||103,155|78,960|
||||103,755|79,745|
|Creditors<br>Amounts<br>falling due within one year|||~B,|~4.5|
|Net Current|Assets||95,010|75,130|
|Total assets|less current liabilities||55.D10|75,130|
|Funds|||||
|Unrestricted|funds|12|95,010|75,130|
|Total funds|carried forward||55,D1~|75,13D|



## 




## 




## 

## 

## 




## 



## 

## 

|Grants||||
|---|---|---|---|
|Althea Company<br>Camurus<br>Ltd||6,000|10,500<br>14,000|
|Ethypharm<br>Indivior|UK Ltd|650<br>2,000|5,100|
|||6,65D|29.600|



|INCOME FROM CHARITABLE ACTIVITIES|2022|2021|
|---|---|---|
|Membership|64,146|49,015|
|Conference<br>& training|6,300|10,855|
|Other income||1,350|
||70,556|~1,220|



## 

|and 31 Janua|ry|2021.|2021.||||
|---|---|---|---|---|---|---|
|NDIT||CHARITABL||ACTIVITIES|2022|2021|
|External<br>advisory||&supervision|work||45,662|55,253|
|Website, newsletter<br>& publicity|||||7,807|7,538|
|Conference|and|training<br>activities|||360|10|
|Travel &general||administration|costs||2,250|161|
|Accountancy|&professional<br>fees||||2,310|1,591|
|Independent|Examiners Fees|||||960|
|Bad Debt|||||685||
|Other costs|||||142|652|
||||||59.216|66,165|



## 



## 

## 

## 

## 

## 

|10.|DEBTORS||||||||2022|2021|
|---|---|---|---|---|---|---|---|---|---|---|
||Amounts<br>falling|due|within one year:||||||||
||FDAP Outstanding||||||||||
||Addiction<br>Professionals||Ltd outstanding||||||600|785|
||||||||||6M|785|
|11.|CREDITORS||||||||2022|2021|
||Amounts<br>faglng|due|within one year:||||||||
||Trade creditors and accruals||||||||8,745|4,615|
||||||||||8,745|4,61~|
|12.|UNR<br>T<br>I|FUNDS|||||||||
|||||Balance||at|Incoming||Outgoing|Balance at|
||Year en<br>1Janus||2022|~0470RD||21|~R~urc||Lt~or<br>IIE|01/02/2022|
|||||||6||6|6|6|
||General funds||||75,130|||79,096|(59,216)|95,010|
||Total funds||||||||||
|13.|UNRE6TRICED|FUNDS|||||||||
|||||Balance||at|Incoming||Outgoing|Balance at|
||Year ended 31Janus||2021|0~470R20 0|||~R||~R~u|~1/ ~2021|
|||||||||6|5|5|
||General funds||||50,464|||90,831|(66,165)|75,130|
||Total funds||||50404|||~It 031|~00,765|75 130|
||Name offund||Descrl|tion|nature an||u|uses ofthe fund|||



## 



## 

## 

|||||Unrestricted|
|---|---|---|---|---|
|Year ended 31||nua|0 2|~fund|
|||||K|
|Current <br>Current|Assets<br>Liabilities|||103,755<br>~5,745|
|||||55515|
|||||~ngf ~ite|
|Year ended 31||an|2021|funds|
|||||E|
|Current <br>Current|Assets<br>Liabilities|||79,745<br>~4,575|
|||||75,130|



##